Patents by Inventor Jiaming Gao

Jiaming Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260335315
    Abstract: The present disclosure relates to a combination of an FAK inhibitor, a topoisomerase inhibitor, and an immune checkpoint inhibitor for use in treating a tumor. The present disclosure also relates to a combination of an FAK inhibitor and a topoisomerase inhibitor for use in treating a tumor.
    Type: Application
    Filed: September 15, 2023
    Publication date: October 29, 2026
    Inventors: Baoyuan Zhang, Zuebin Liu, Jiaming Gao, Ping Zhang, Ran Pang, Zaiqi Wang
  • Publication number: 20260325517
    Abstract: Provided are a composition of an FAK inhibitor, a microtubule inhibitor and an immune checkpoint inhibitor, a kit composed of the composition, and use thereof in the preparation of a medicament for treating a tumor.
    Type: Application
    Filed: August 22, 2023
    Publication date: October 22, 2026
    Inventors: Baoyuan Zhang, Xuebin Liu, Jiaming Gao, Ping Zhang, Ran Pang, Zaiqi Wang
  • Publication number: 20260315467
    Abstract: An FAK inhibitor, an epidermal growth factor receptor tyrosine kinase inhibitor, and an immune checkpoint inhibitor are combined to treat tumors, and an FAK inhibitor and an epidermal growth factor receptor tyrosine kinase inhibitor are combined to treat tumors.
    Type: Application
    Filed: September 5, 2023
    Publication date: October 15, 2026
    Inventors: Baoyuan Zhang, Xuebin Liu, Jiaming Gao, Ping Zhang, Ran Pang, Zaiqi Wang
  • Patent number: 11986477
    Abstract: The present disclosure relates to the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of tumors.
    Type: Grant
    Filed: November 6, 2023
    Date of Patent: May 21, 2024
    Assignee: INXMED (NANJING) CO., LTD.
    Inventors: Baoyuan Zhang, Xuebin Liu, Jiaming Gao, Ping Zhang, Ran Pang, Zaiqi Wang
  • Publication number: 20240082247
    Abstract: The present disclosure relates to the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of tumors.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 14, 2024
    Inventors: Baoyuan Zhang, Xuebin Liu, Jiaming Gao, Ping Zhang, Ran Pang, Zaiqi Wang